ILC Publications Library

The Lobular Breast Cancer Alliance (LBCA) has compiled a reference list of research publications related to lobular breast cancer, also known as invasive lobular carcinoma (ILC).

The library contains nearly 300 studies from the year 2000 to the present.  The table that follows is our complete collection of studies. 

Publications and Articles

Studies added most recently are featured in alphabetical order under the headline New Additions at the beginning of the Publications and Articles list below.  This is followed by previously added studies. We update this research list periodically. Follow @LobularBCA and #lobular on Twitter to access up-to-date research.

How to use this table: Use the headers on the columns to sort by category. Use the Search function to locate specific study topics. To read a full article with restricted access consult a local medical library or purchase access to the full article. The LBCA can not send or link to restricted articles due to license limitations. Suggestions for additions or changes to this list can be emailed to info@lobularbreastcancer.org for review. People with lobular breast cancer utilizing this publications library are encouraged to discuss all studies with their providers.

AuthorTitlePublicationDateType of ArticleeGeneral SubjecttSpecific
Subject
NEW ADDITIONS
AliagaEvolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastasesEJC European Journal of Cancer2023RetrospectiveClinicopathologicalPrimary vs Metastatic Tumors
AmirA role for breast ultrasound Artificial Intelligence decision support in the evaluation of small invasive lobular carcinomasClinical Imaging2023RetrospectiveImagingArtificial Inteligence
ArceEvaluation of an Artificial Intelligence System for Detection of Invasive Lobular Carcinoma on Digital MammographyCureus2023RetrospectiveImagingArtificial Inteligence
BarakatAchieving Intraperitoneal Disease Control Using Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Two Cases of Metastatic Breast CancerCureus2023Case reportsSurgeryPeritoneal Metastatsis
BarbieriA Rare Case of Duodenal Metastasis from Lobular Breast Cancer: From Diagnosis to SurgeryCase Report Oncology2023Case reportsMetastasisDuodenal Metastasis
BonninPerformance of [18F]FDG-PET/CT Imaging in First Recurrence of Invasive Lobular CarcinomaJournal of Clinical Medicine2023RetrospectiveImagingFDG PET/CT
BottoniDiagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective studyEur J Nucl Med Mol Imaging2023ProspectiveImagingFES PET/CT
ClellandQuantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomesBreast Canc Res Treat2023RetrospectiveClinocopathologicalER low +
CoffeyBreast Radiologists’ Perceptions on the Detection and Management of Invasive Lobular Carcinoma: Most Agree Imaging Beyond Mammography Is WarrantedJournal of Breast Imaging2024RetrospectiveImagingImaging Methods
CovingtonProspective Pilot Study of 18F-Fluoroestradiol PET/CT in Patients With Invasive Lobular CarcinomasAJR2023ProspectiveImagingFES PET/CT
DavisCirculating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer.EBioMedicine2022RetrospectiveGenomicsctDNA
Dołęga-KozierowskiMultimodality imaging in lobular breast cancer: Differences in mammography, ultrasound, and MRI in the assessment of local tumor extent and correlation with molecular characteristicsFront Oncol2022RetrospectiveImagingImaging Modalities/Breast
EshetThe Role of 68Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast CancerClin Nucl Med2023ProspectiveImagingFAPi Pet/CT
GiraldiFDG and Non-FDG Radiopharmaceuticals for PET Imaging in Invasive Lobular Breast CarcinomaBiomedicines2023ReviewImagingPET Imaging
GokerTumor-Infiltrating Lymphocytes and PD-L1 Expression in Pleomorphic Lobular Breast CarcinomaCancers2023RetrospectiveClincopathologic/GenomicsPleomorphic ILC
KaurArea Deprivation Index in patients with invasive lobular carcinoma of the breast: associations with tumor characteristics and outcomesCancer Epidemiol Biomarkers2023RetrospectiveEpidemiologyTumor Characteristics and outcomes
KawaguchiHigh-accuracy prediction of axillary lymph node metastasis in invasive lobular carcinoma using focal cortical thickening on magnetic resonance imagingBreast Cancer2023RetrospectiveImagingMRI
LiA study of clinical and molecular characteristics in bilateral primary breast cancerCancer Med2023RetrospectiveCllnicopathologicalBilateral Breast Cancer
LobbesThe performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancerEur J Radiol2023RetrospectiveImagingCEM/MRI
MouabbiAbsence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinomaEJC European Journal of Cancer2023RetrospectivePrognosisLCIS
MouabbiHistology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapiesNPJ Breast Cancer2022RetrospectiveClinicopatholicalTargeted therapy in ILC vs. IDC
MuradaliPreoperative Breast Magnetic Resonance Imaging: An Ontario Health (Cancer Care Ontario) Clinical Practice GuidelineCurr Oncol2023ReviewImagingMRI
NareshAn unwelcome guest: two cases of colonic metastatic lobular breast cancerJ Surg Case Rep2021Case reportsMetastasisColonic Metastases
NasrazadaniMixed invasive ductal lobular carcinoma is clinically and pathologically more similar to invasive lobular than ductal carcinomaBr J Cance2023RetrospectiveClinicopathologicalMixed ILC/IDC
OnegaDigital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinomaBreast Cancer Res Treat2023RetrospectiveImagingDigital Mammography/Tomsynthsis
OnkarImmune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironmentNat Cancer2023Lab ResearchGenomicsImmunology
PeresluchaInvasive Lobular Carcinoma: A Review of Imaging Modalities with Special Focus on Pathology ConcordanceHealthcare2023ReviewImagingMRI vs CEM
RamalingamSuccessful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to TreatmentAnn Surg Oncol2023RetrospectiveSurgeryMenopausal Status
RibinkarAssociation between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapyRadiol Oncol2023RetrospectiveGenomicsPik3CA mutations
RichardCharacterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast CancerClin Cancer Research2020Lab ResearchGenomicsMutations in metastatic ILC
RothschildPredictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic TherapyAnn Surg Oncol2023RetrospectiveClinicopathologicalLocal Recurrances
RothschildHER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional seriesBreast Cancer Res Treat2023RetrospectiveClinicopathologicalHer2 low
SflomosOptimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast CarcinomaCancers2023Lab ResearchILC ModelsTNBC-ILC
ThillTreatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPALBreast Cancer Res Treat2023ProspectiveClinicopathologicalPrognosis
ThomasRare subtypes of triple negative breast cancer: Current understanding and future directionsNPJ Breast Cancer2023RetrospectiveClinicopathologicalTNBC Subtypes
Van BaelenAssociation of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancerEJC European Journal of Cancer2023RetrospectivePrognosisBody mass Index
VoorwerkPD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial. . Nat Cancer2023ProspectiveClinicopathologicalImmunotherapy
YuClinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?NPJ Breast Cancer2023RetrospectiveClincopathologic/GenomicsLobular Like IDC's (LMMCA)
STUDIES ADDED
2018-2022
AbdallahMetastatic Breast Lobular Carcinoma to Unusual Sites: A Report of Three Cases and Review of LiteraturesJ Med Cases 2020Case ReportMetastasisGI metastases
AbelThe 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database StudyAnn Surg Oncology2022RetrospectiveClinicopathologicalPrognostic Biomarkers
AbelDecreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?NPJ Breast Cancer2021RetrospectiveClinical Trials RECIST criteria
AbelBreast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greaterAmer J of Surgery2020RetrospectiveSurgeryPrognosis
AbreuInvasive lobular
carcinoma: a rare presentation in the male breast		BMJ Case report2016Case ReportClinicopathologicalMale ILC
AdachiComparison of
clinical outcomes between luminal invasive ductal carcinoma and luminal
invasive lobular carcinoma		BMC Cancer2016RetrospectiveClinicopathologicalPrognosis
AdachiComparison of sentinel
lymph node biopsy between invasive lobular carcinoma and invasive ductal
carcinoma		Breast Cancer2018RetrospectiveSurgerySentinal Lymph Node biopsy
AlexanderAssessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast CancerCancers (Basel)2022ClinicopathologicalGenomicsE-Cadherin
AllenVIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft modelsBritish Journal of Cancer2022Lab ResearchCancer BiologyILC Models
AnCdh1
and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular
Carcinoma of the Breast		Cell Reports2018Laboratory ResearchGenomicsLab Models
AnwarInvasive
lobular carcinoma of the breast: Should this be regarded as a chronic
disease?		Intl J Surg2010RetrospectiveClinicopathologicalPrognosis
ArpinoInfiltrating
lobular carcinoma of the breast: tumor characteristics and clinical outcome		Breast Cancer Research2004RetrospectiveClinicopathologicalCharacteristics of ILC
ArthurMolecular
Changes in Lobular Breast Cancers in Response to Endocrine Therapy		Cancer Res2014RetrospectiveGenomicsEndocrine Therapy
BagliaAlcohol Intake
and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status
Among Women Aged 55 to 74 Years		Hormones and Cancer2017RetrospectiveRisk FactorsAlcohol use
BahnassyUnlocking the Mysteries of Lobular Breast Cancer Biology Needs the Right Combination of Preclinical ModelsMol Cancer Res2022ReviewCancer BiologyILC Models
BajramiE-cadherin/ROS1
inhibitor synthetic lethality in breast cancer		Cancer Disc2018Lab ResearchCancer BiologyE-cadherin
Barroso-SousaDifferences
between invasive lobular and invasive ductal carcinoma of the breast: results
and therapeutic implications		Adv Med Onc2016ReviewClinicopathologicalTherapy Response and Resistance
BergDiagnostic accuracy of
mammography, clinical examination, US, and MR imaging in preoperative
assessment of breast cancer		Radiology2004RetrospectiveImagingImaging Methods
BergeronTriple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutationsNature2021RetrospectiveGenomicsTriple-negative ILC
BergeronAn exceptional
metaplastic lobular breast carcinoma diagnosed through exome sequencing.		J Clin Path2020Case ReportGenomicsMetaplastic Carcinoma
BeumerPrognostic Value of MammaPrint® in Invasive Lobular Breast CancerBiomark Insights2016RetrospectiveClinicopathologicalPrognostic Biomarkers
BertozziPrevalence, risk
factors, and prognosis of peritoneal metastasis from breast cancer		Springer Plus2015RetrospectiveMetastasisPeritoneal Metastasis
BhaludinA review on the added value of whole-body MRI in metastatic lobular breast cancerEur Radiol2022ReviewImagingMRI
BlohmerPatient
treatment and outcome after breast cancer orbital and periorbital metastases:
a comprehensive case series including analysis of lobular versus ductal tumor
histology		Breast Cancer Res2020RetrospectiveMetastasisOribital Metastasis
Bodopati18F-FES PET/CT Improves the Detection of Intraorbital Metastases in Estrogen-Receptor-Positive Breast Cancer: Two Representative Cases and Review of the LiteratureTomography2022Case ReportsImagingOrbital metastases
BrunerLoss of
E-Cadherin-Dependent Cell–Cell Adhesion and the Development and
Progression of Cancer		CSH Perspectives2018ReviewCancer BiologyE-cadherin
BrunelloFGFR-1
amplification in metastatic lymph-nodal and haematogenous lobular breast
carcinoma		J Exp Clin Cancer Res2012RetrospectiveGenomicsFGFR1 mutation
BusbaitOccult Invasive Lobular Carcinoma: Presenting as an Axillary Skin Metastatic Lesion Underwent Neoadjuvant Endocrine Therapy and Surgical ResectionBreast Cancer 2022Case StudyMetastasisSkin Metastasis
CaoFrequent amplifications
of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma		Cancer Letter2019Lab ResearchCancer biologyGenomics
CarbogninTargeted next-generation
sequencing identifies genomic abnormalities potentially driving the prognosis
of early-stage invasive lobular breast carcinoma patients stratified
according to a validated clinico-pathological model.Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model		Breast2020Lab ResearchGenomicsPrognosis
CarcoforoInfiltrating Lobular Carcinoma of
the Breast Presenting as Gastrointestinal Obstruction: A Mini Review		Journal of Cancer2012Case ReportMetastasisGI Metastasis
ChamalidouSurvival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow upThe Breast2021Retrospective ClinicopathologicalPrognosis
ChenSingle-Cell Transcriptomic
Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells		Cancer Res2021Lab ResearchCancer BiologyGenomics
ChenInvasive
lobular carcinoma of the breast: A special histological type compared with
invasive ductal carcinoma		PLOS One2017RetrospectiveClinicopathologicalPrognosis
Chen21-gene recurrence score
and adjuvant chemotherapy decisions in patients with invasive lobular breast
cancer		Biomarkers in Medicine2018RetrospectiveGenomicsPrognostic Biomarkers
ChristgenInter-observer agreement for the histological diagnosis of invasive lobular breast carcinomaJ Pathol Clin Res2022Lab ResearchClinicopathologicalDiagnosis
ChristgenDifferential
impact of prognostic parameters in hormone receptor-positive lobular breast
cancer		Cancer2020RetrospectiveClinicopathologicalPrognostic Biomarkers
ChristgenSubclonal
analysis in a lobular breast cancer with classical and solid growth pattern
mimicking a solid‐papillary carcinoma		J Patho Clin Res2017Case ReportGenomicsPapillary Carcinoma
ChristgenLobular breast cancer:
Clinical, molecular and morphological characteristics		Pathology2016ReviewCancer biologyPathology
ChristgenLobular breast
cancer: molecular basis, mouse and cellular models		Breast Cancer Res2015ReviewCancer biologyILC Models
ChristgenOncogenic PIK3CA
Mutations in Lobular Breast Cancer Progression		Genes Chromosones Cancer2013RetrospectiveGenomicsPIK3CA Mutations
ChristofanilliInvasive Lobular
Carcinoma Classic Type: Response to Primary Chemotherapy and Survival
Outcomes		Journal of Clinical Oncology2005RetrospectiveClinicopathologicalChemotherapy
CirielloComprehensive Molecular
Portraits of Invasive Lobular Breast Cancer		Cell2015Lab ResearchGenomicsGenetic basis of ILC
CoccoInvasive Lobular Breast Cancer: Data to Support Surgical Decision MakingAnn Surg Onc2021Retrospective SurgeryMRI
ConfortiBiological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterationsBreast2021RetrospectiveClinicopathologicalTNBC
ConfortiEndocrine-responsive
lobular carcinoma of the breast: features associated with risk of late
distant recurrence		Breast Cancer Res2019RetrospectiveRisk FactorsLate Recurrence/Metastasis
ConstantiniDiagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral MammographyJ Pers med2022RetrospectiveImagingMRI/CESM
CoronaManagement of the axilla
in breast cancer: outcome analysis in a series of ductal versus lobular
invasive cancers		Breast Cancer Res Treat2019RetrospectiveSurgeryLymph node metastasis
CorsoHereditary lobular breast cancer with an emphasis on E-cadherin genetic defectJ Med Genet2018ReviewHereditary breast cancerGermline CDH1 mutation
CorsoCDH1 germline mutations
and hereditary lobular breast cancer.		Fam Cancer2016ReviewHereditary breast cancerGermline CDH1 mutation
CostarelliPleomorphic
lobular carcinoma: is it more similar to a classic lobular cancer or to a
high-grade ductal cancer?		Breast Cancer2017RetrospectiveCancer biologyPleomorphic ILC
CrownIntraoperative radiation
therapy in early-stage breast cancer: Presence of lobular features is not
associated with increased rate of requiring additional therapy.		Am J Surg2019RetrospectiveSurgeryIntra-operative Radiation
Da RosHER2-positive lobular versus
ductal carcinoma of the breast: pattern of first recurrence and molecular
insights. 		Clin Breast Cancer2018RetrospectiveClinicopathologicalHer2+ ILC
DabbsLobular versus ductal
breast neoplasms: the diagnostic utility of p120 catenin		Am J Surg Path2007RetrospectiveClinicopathologicalP120-Catenin
DaniaAssociations of
race and ethnicity with risk of developing invasive breast cancer after
lobular carcinoma in situ		Breast Cancer Res2019RetrospectiveRisk FactorsRace/Ethnicity
DashevskyAppearance of
untreated bone metastases from breast cancer on FDG PET/CT: Importance of
histologic subtype		Eur
J Nucl Med Mol Imaging		2015RetrospectiveImagingBone Metastases
DavisCirculating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancerE Bio Medicine2022RetrospectiveMetastasisGenomics
de GregorioThe impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS CBr J Cancer2022ReviewClinicopathologicalChemotherapy
de grootαE‐catenin
is a candidate tumor suppressor for the development of
E‐cadherin‐expressing lobular‐type breast cancer		J Pathology2018Lab ResearchCancer BiologyE-cadherin
de
Nonneville		Adjuvant Chemotherapy in
Lobular Carcinoma of the Breast: A Clinicopathological Score Identifies
High-Risk Patient With Survival Benefit		Breast Cancer Res2019RetrospectiveClinicopathologicalChemotherapy
DelpechClinical benefit
from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal
and lobular carcinomas		British Journal of Cancer2013RetrospectiveClinicopathologicalChemotherapy
DeniziatERBB2 mutations
associated with solid variant of high-grade invasive lobular breast
carcinomas		Oncotarget2016RetrospectiveGenomicsERBB2(HER2) Somatic Mutations
DerksenMammary-specific
inactivation of E-cadherin and p53 impairs functional gland development and
leads to pleomorphic invasive lobular carcinoma in mice		Dis Model Mech2011Lab ResearchCancer Biology ILC Models
DerksonSomatic
inactivation of E-cadherin and p53 in mice leads to metastatic lobular
mammary carcinoma through induction of anoikis resistance and angiogenesis		Cancer Cell2006Lab ResearchCancer BiologyILC Models
De SchepperResults of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancerMod Pathology2022GuidelinesClinicopathological Diagnosis
DesmedtGenomic
Characterization of Primary Invasive Lobular Breast Cancer		Journal of Clinical Oncology2016Lab ResearchGenomicsMutations in ILC
DesmedtESR1 mutations in
metastatic lobular breast cancer patients		npj Breast Cancer2019RetrospectiveGenomicsESR1 Mutation
DesmedtImmune
Infiltration in Invasive Lobular Breast Cancer		J Natl Cancer Inst.2018RetrospectiveCancer biologyImmunology
DessauvagieInvasive
lobular carcinoma of the breast: assessment of proliferative activity using
automated Ki-67 immunostaining		Pathology2019RetrospectiveClinicopathologicalKi67
DiPiroLobular breast cancer:
patterns of intraabdominal metastatic spread on imaging and
prognosticsignificance.		Abdom Radiology2019RetrospectiveMetastasisAbdominal Metastasis
DitchiLow risk of
invasive lobular carcinoma of the breast in carriers of BRCA1 and TP53
(Li-Fraumeni syndrome) germline mutations		Breast Journal2018RetrospectiveHereditary breast cancerBRCA / p53 mutation
DixonInvasive lobular
carcinoma: response to neoadjuvant letrozole therapy		Breast Cancer Res Treat2011RetrospectiveClinicopathologicalEndocrine Resistance
DjerroudiInvasive Lobular Carcinoma of the Breast: Toward Tailoring Therapy?JNCI2022Editorial ClinicopathologicalPrognosis
DonaldsonBreast cancer risk
associated with atypical hyperplasia and lobular carcinoma in situ initially
diagnosed on core-needle biopsy		Cancer2018RetrospectiveRisk FactorsLCIS/Hyperplasia
DossusLobular breast
cancer: incidence and genetic and non-genetic risk factors		Breast Cancer Research2015ReviewRisk FactorsIncidence
DuKey regulators of lipid
metabolism drive endocrine resistance in invasive lobular breast cancer		Breast Cancer Research2018Lab ResearchCancer biologyEndocrine Resistance
ElangovanLoss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast CarcinomaMol Cancer Res2022Lab ResearchCancer BiologyE-cadherin and cell signaling
EngstromInvasive lobular
breast cancer: the prognostic impact of histopathological grade, E-cadherin
and molecular subtypes		Histopathology2015RetrospectiveClinicopathologicalPrognosis
FeltsAn Analysis of Oncotype
DX Recurrence Scores and Clinicopathologic Characteristics in Invasive
Lobular Breast Cancer.		Breast j2017RetrospectiveGenomicsPrognostic Biomarkers
FimereliTiming evolution of lobular breast cancer through phylogenetic analysisEBioMedicine 2022Retrospective GenomicsMetastasis
Findlay-ShirrasPopulation Trends in Lobular Carcinoma of the Breast: The Ontario ExperienceAnn Surg Oncol2020Retrospective Clinicopathological Prognosis
FitzpatrickAssessing CSF ctDNA to improve diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasisClin Canc Research2022Retrospective GenomicsLeptomingeal metastasis
Flores-DiazImpact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patientsBreast Cancer Res Treat 2019Retrospective Clinicopathological Prognosis
FranzoiLeptomeningeal
carcinomatosis in patients with breast cancer.		Crit Rev Oncol Hematol2019ReviewMetastasisLeptomeningal Metastasis
GainerInvasive Lobular
Carcinoma Predicts Micrometastasis in Breast Cancer		Journal or Surgical Research2012Lab ResearchCancer biologyMetastasis
GambleAssociation Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer RiskJama Surgery2021ProspectiveHereditary RiskGermline CDH1 Mutation
GaoPeritoneal Metastasis After Treated With Abemaciclib Plus Fulvestrant for Metastatic Invasive Lobular Breast Cancer: A Case Report and Review of the LiteratureFrontiers in Endocrinology2021Case Report MetastasisPeritoneal Metastasis
GaoCDK4/6 inhibitor
treatment for patients with hormone receptor-positive, HER2-negative,
advanced or metastatic breast cancer		Lancet Oncol2019RetrospectiveClinicopathologicalCDK4/6 inhibitor response
Gomez-CuadradoCharacterisation of the Stromal Microenvironment in Lobular Breast CancerCancers2022Lab ResearchCancer BioligyTumor Microenvironment
GrabenstetterE-cadherin
immunohistochemical expression in invasive lobular carcinoma of the breast:
correlation with morphology and CDH1 somatic alterationsE-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations		Human Pathology2020RetrospectiveClinicopathologicale-Cadherin/CDH1
GroteERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancerModern Pathology2022RetrospectiveGenomicsERBB2 mutations
GuiuInvasive lobular breast
cancer and its variants: how special are they for systemic therapy decisions?		Crit Rev Onco Hematology2014ReviewClinicopathologicalTherapy Response and Resistance
GuvenSentinel Lymph
Node Metastasis in Invasive Lobular Carcinoma of the Breast		European Journal Br Helath2018RetrospectiveMetastasisLymph Node Invasion
HaBreast MR Imaging
before Surgery: Outcomes in Patients with Invasive Lobular Carcinoma by Using
Propensity Score Matching		Radiology2018RetrospectiveImagingMRI
HansfordHereditary
Diffuse Gastric Cancer Syndrome -CDH1 Mutations and Beyond		Jama Oncol2015RetrospectiveHereditary breast cancerGenetic CDH1 mutation
HeHER2 Positive and HER2 Negative Classical Type Invasive Lobular Carcinomas: Comparison of Clinicopathologic FeaturesCurr Oncology2021RetrospectiveClinicopathologicalHer2+ ILC
HarrellEstrogen induces
c-Kit and an aggressive phenotype in a model of invasive lobular breast
cancer		Oncogeniesis2017Lab ResearchCancer BiologyEstrogen signaling
HarrisonGenomic profiling of
pleomorphic and florid lobular carcinoma in situ reveals highly recurrent
ERBB2 and ERRB3 alterations		Mod Pathol2019RetrospectiveGenomicsERBB2 ,ERBB3/(Her2) Mutations
HeDistant
Metastatic Disease Manifestations in Infiltrating Lobular Carcinoma of the
Breast		AJR2014ReviewMetastasisMetastatic Sites
HoganComparison of
18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular
Carcinoma Versus Invasive Ductal Carcinoma		J Nucl Med2015RetrospectiveImagingFDG PET/CT
HornsveldRestraining
FOXO3-dependent transcriptional BMF activation underpins tumour growth and
metastasis of E-cadherin-negative breast cancer		Cell Death Diff2016Lab ResearchCancer BiologyMetastasis /E-cadherin
HoussamiMeta-analysis of
pre-operative magnetic resonance imaging (MRI) and surgical treatment for
breast cancer		Breast Canc Res Treat2017ReviewImagingMRI
HovisAccuracy of Preoperative Breast MRI versus Conventional Imaging in Measuring Pathologic Extent of Invasive Lobular CarcinomaJournal of Breast Imaging2021RetrospectiveImagingMRI
HuAdjuvant
chemotherapy could not bring survival benefit to HR-positive, HER2-negative,
pT1b-c/N0–1/M0 invasive lobular carcinoma of the breast: a propensity
score matching study based on SEER database		BMC Cancer2020RetrospectiveClinicopathologicalChemotherapy
InoueSpecific sites of
metastases in invasive lobular carcinoma: a retrospective cohort study of
metastatic breast cancer		Breast Cancer2017RetrospectiveMetastasisMetastatic Sites
IorfidaInvasive lobular breast
cancer: subtypes and outcome		Breast Cancer Res Treat2012RetrospectiveClinicopathologicalPrognosis
IshidaPleomorphic
lobular carcinoma in a male breast: a case report with review of the
literature		Int J Clin Exp Pathol2013Case ReportClinicopathologicalMale ILC
JacobsIssues Affecting the
Loco-regional and Systemic Management of Patients with Invasive Lobular
Carcinoma of the Breast		The Breast Journal2015ReviewClinicopathologicalTherapy Response and Resistance
JenkinsThe 70-gene signature test as a prognostic and predictive biomarker in patients with invasivelobular breast cancerBreast Cancer Res Treat2021RetrospectiveGenomicsGene Signatures
JohnsonLobular breast cancer
series: imaging		Breast Cancer Res2015ReviewImagingImaging Modalities
KarjolBladder
Metastasis from Breast Cancer: A Systematic Review		Cereus2020ReviewClinicopathologicalBladder Metastasis
KizyImpact of the 21-gene
recurrence score on outcome in patients with invasive lobular carcinoma of
the breast		Breast Cancer Res2017RetrospectiveGenomicsPrognostic Biomarkers
KlarenbeekResponse of
metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly
mediated by the adaptive immune system		Oncoimmunology2020Lab ResearchCancer BiologymTor Inhibition
KorhonenThe
impact of lobular and ductal breast cancer histology on the metastatic
behavior and long term survival of breast cancer patients		The Breast2013RetrospectiveClinicopathologicalMetastasis
KurozumiTargetable ERBB2
mutation status is an independent marker of adverse prognosis in estrogen
receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a
retrospective in silico analysis of public datasets		Breast Cancer Research2020RetrospectiveCancer BiologyERBB2/Her2 mutations
KutasovicBreast cancer
metastasis to gynaecological organs: a clinico‐pathological and
molecular profiling study		J Pathol Clin Res2019RetrospectiveGenomicsGynocological Metastasis
LaenkholmPopulation-based Study of
Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen
Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal
Breast Cancer.		Clin Breast Cancer2020RetrospectiveGenomicsPrognostic Biomarkers
LanglandsContralateral breast
cancer: incidence according to ductal or lobular phenotype of the primary		Clinical Radiology2016RetrospectiveClinicopathologicalContralateral Breast Cancer
LeeChromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomasBreast Cancer Research2022Lab ResearchGenomicsEpigenomics
LeNoue-NewtonNatural History and Characteristics of ERBB2-mutated Hormone Receptor–positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case–control Study from AACR Project GENIEClin Canc Research 2022Retrospective GenomicsERBB2 mutations
LevineFGFR4
overexpression and hotspot mutations in metastatic ER+ breast cancer are
enriched in the lobular subtype		NPJ Breast
Cancer		2019Lab ResearchGenomicsMetastasis
LiHormone replacement
therapy in relation to risk of lobular and ductal breast carcinoma in
middle-aged women.		Cancer2000RetrospectiveRisk FactorsHormone Replacement Therapy
LiChanging Incidence Rate
of Invasive Lobular Breast Carcinoma among Older Women		Cancer2000RetrospectiveRisk FactorsIncidence
LiaoThe
Clinicopathological Features and Survival Outcomes of Different Histological
Subtypes in Triple-negative Breast Cancer		J Cancer2018RetrospectiveClinicopathologicalTriple-negative ILC
LienFrequent alterations of
HER2 through mutation, amplification, or overexpression in pleomorphic
lobular carcinoma of the breast.		Breast Canc Res Treat2017RetrospectiveGenomicsHER2+ and mutations in PLC
LoganMolecular
drivers of lobular carcinoma in situ		Breast Cancer Res2015ReviewCancer biologyLCIS
LokadasanMetastatic
lobular carcinoma of breast mimics primary cervix carcinoma: two case reports
and a review of the literature		ecancermedicalscience2015Case ReportMetastasisCervical Metastasis
LopezInvasive Lobular
Carcinoma of the Breast: Spectrum of Mammo- graphic, US, and MR Imaging
Findings		Radiographics2009ReviewImagingImaging modalities
LuvetaInvasive
Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic
Strategy		Oncol and Therapy2019ReviewCancer BiologyGenomics and Therapeutic strategies
Makower The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysisNPJ Breast2022RetrospectiveClinicopathologicalPrognostic Biomarkers
MamtaniLobular Breast Cancer
Different Disease, Different Algorithms		Surgical Oncol Cinics2018ReviewClinicopathologicalGenomics of ILC
MamtaniLobular
Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG
Z0011-Eligible Breast Cancer		Ann Surg Oncol2019RetrospectiveSurgeryLymph Node Dissection
MannMRI compared to
conventional diagnostic work-up in the detection and evaluation of invasive
lobular carcinoma of the breast		Breast Cancer Res2008ReviewImagingMRI
MarmorRelative
Effectiveness of Adjuvant Chemotherapy for Invasive Lobular Compared With
Invasive Ductal Carcinoma of the Breast		Cancer2017RetrospectiveClinicopathologicalChemotherapy
MathewDistinct Pattern
of Metastases in Patients with Invasive Lobular Carcinoma of the Breast		Geburtshilfe Frauenheilkd2017RetrospectiveMetastasisMetastatic Sites
MathieuThe poor responsiveness
of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be
explained by their biological profile		Eur J Cancer2004RetrospectiveClinicopathologicalChemotherapy
McCart ReedThe Genomic Landscape of Lobular Breast CancerCancers (Basel)2021RetrospectiveGenomicsPrognosis
McCart
Reed		Invasive lobular
carcinoma of the breast: the increasing importance of this special subtype		Breast Cancer Res2021ReviewCancer BiologyGenomics and Pathology of ILC
McCart
Reed		Mixed
ductal-lobular carcinomas: evidence for progression from ductal to lobular
morphology		J Pathology2018RetrospectiveCancer biologyMixed ILC/IDC
McCart
Reed		LobSig is a
multigene predictor of outcome in invasive lobular carcinoma		NPJ Breast Cancer2019Lab ResearchGenomicsGene signatures
McCart
Reed		An epithelial to mesenchymal
transition programme does not usually drive the phenotype of invasive lobular
carcinomas		J Pathology2015Lab ResearchCancer BiologyE-Cadherin
McCart
Reed		Invasive lobular
carcinoma of the breast: morphology, biomarkers and Õomics		Breast Cancer Research2015ReviewCancer biologyGenomics
Metzger-FilhoMagnitude of
trastuzumab benefit in patients with HER2-positive, invasive lobular breast
carcinoma: results from the HERA trial		Journal of Clinical Oncology2013RetrospectiveClinicopathologicalHER2+ ILC
Metzger-FilhoRelative
Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular
Carcinoma in the BIG 1-98 Trial		Journal of Clinical Oncology2015RetrospectiveClinicopathologicalEndocrine Therapy
Metzger-FilhoGenomic grade adds
prognostic value in invasive lobular carcinoma		Ann Onc2013RetrospectiveGenomicsGene Signatures
Metzger-FilhoMixed Invasive
Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of
Histologic Grade		The Oncologist2018RetrospectiveClinicopathologicalMixed ILC/IDC
MichautIntegration of
genomic, transcriptomic and proteomic data identifies two biologically
distinct subtypes of invasive lobular breast cancer		Sci Rep2016Lab ResearchGenomicsGenetic basis of ILC
MillsIncreased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation BrachytherapyThe Oncologist2021RetrospectiveRadiologyRadiation
MohamedThe
overexpression of DNA repair genes in invasive ductal and lobular breast
carcinomas: Insights on individual variations and precision medicine		PLOS One2021RetrospectiveGenomicsDNA damage response
MontagnaLobular Metastatic
Breast Cancer Patients With Gastrointestinal Involvement: Features and
Outcomes		Clinical Breast Cancer2018RetrospectiveMetastasisMetastatic Sites
MontanaghInvasive lobular
carcinoma with papillary features: A newly described variant that poses a
difficult histologic differential diagnosis.		Breast J2020Case ReportClinicopathologalPapillary Carcinoma
MotenCharacterizing lobular
carcinoma of the male breast using the SEER database.		J surg Res2013RetrospectiveClinicopathologicalMale ILC
MouabbiInvasive lobular carcinoma: an understudied emergent subtype of breast cancerBreast Cancer Res Treat2022ReviewClinicopathologicalCharacteristics of ILC
MukhtarChanges
in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery
in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer
Database (NCDB)		Annals of Surg Onc2021RetrospectiveSurgeryNeoadjuvent Therapy Response
MukhtarInvasive
Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future
Directions		Clinical Trials2021ReviewClinicopathologicalClinical Trials
MukhtarBreast Conservation and
Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic
Surgery and Shave Margins in 358 Patients		Annals of Surgical Oncol2018RetrospectiveSurgerySurgical methods
MukhtarMitotic Score and
Pleomorphic Histology in Invasive Lobular Carcinoma of the Breast: Impact on
Disease-Free Survival		Breast Cancer Res Treat2020RetrospectiveClinicopathologicalPleomorphic ILC
NagleLoss of
E-cadherin Enhances IGF1–IGF1R Pathway Activation and Sensitizes Breast
Cancers to Anti-IGF1R/InsR Inhibitors		Clinical Cancer Research2018Laboratory ResearchCancer biologyCell signaling
NarbeThe Distribution of
Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal
Carcinoma of the Breast-Long-Term Prognostic Significance		Cells2020RetrospectiveMetastasisCirculating Tumor Cells
NarbeInvasive lobular
carcinoma of the breast: long-term prognostic value of Ki67 and histological
grade, alone and in combination with estrogen receptor		Springer Plus2014RetrospectiveClinicopathologicalPrognosis/Ki67
NardoneA Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast CancerCancer Res2022Lab ResearchCancer BiologyEpigenomics
NunesPrognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular CarcinomaClin Cancer Res2021RetrospectivePrognosisPrognostic Biomarkers
OesterreichClinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast CancerJNCI2022RetrospectiveClinicopathologicalPrognosis
OesterreichOpening the
Door for Immune Oncology Studies in Invasive Lobular Breast Cancer		J Natl Cancer Inst.2018EditorialCancer biologyImmunology
O'ConnorDifferences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysisBreast2022ReviewSurgeryNeoadjuvent chemotherapy
OkinesClinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experienceBreast Cancer Res Treat2022RetrospectiveClinicopathologicalTNBC, Her2 ILC
OliveraEvolving
concepts in breast lobular neoplasia and invasive lobular carcinoma, and
their impact on imaging methods		Insights Imaging2014ReviewImagingImaging modalities
OrvietoClinicopathologic
characteristics of invasive lobular carcinoma of the breast		Cancer2008RetrospectiveClinicopathologicalPrognosis
OrlandiPalbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient SeriesJ Pers med2020RetrospectiveClinicopathologicalMetastatic ILC
ParejaThe genomic landscape of metastatic histologic special types of invasive breast cancernpj breast cancer2020RetrospectiveGenomicMutations in Metastatic ILC
PateHow Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer ResearchCancers2021ReviewResearchAdvocacy
PatelCT, MRI and PET imaging in peritoneal malignancyCancer Imaging2011ReviewImagingPeritoneal Metastasis
PatelValue Added of
Preoperative Contrast-Enhanced Digital Mammography in Patients With Invasive
Lobular Carcinoma of the Breast		Clinical Breast Cancer2018RetrospectiveImagingMammography methods
Perez-GarciaEfficacy of Single-Agent
Chemotherapy for Patients with Advanced Invasive LobularCarcinoma		The Oncologist2018RetrospectiveClinicopathologicalChemotherapy
PestalozziDistinct
Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the
Breast: Combined Results of 15 International clinical trials		J Clin Oncol2008RetrospectiveClinicopathologicalPrognosis
PetridisFrequency of Pathogenic
Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic
Lobular Breast Cancer		Cancer Epidemiol Biomark2019RetrospectiveGenomicsGenetic basis of ILC
PhalakSupplemental ultrasound
screening in patients with a history of lobular neoplasia		The Breast Journal2018RetrospectiveImagingLobular Neoplasia
PhippsRisk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening populationCancer Epidemiol Biomarkers Prev2010RetrospectiveClinicopathologicalRisk Factors
PramodComprehensive
review of molecular mechanisms and clinical features of invasive lobular
cancer		The Oncologist2021ReviewClinicopathologicalMolecular and clinical features
of ILC
RaapHigh frequency
of lobular breast cancer in distant metastases to the orbit		Cancer Med2015RetrospectiveMetastasisOribital Metastasis
RaapLobular carcinoma in
situ and invasive lobular breast cancer are characterized by enhanced
expression of transcription factor AP-2β.		Lab Invest2017Lab ResearchCancer BiologyGenomics of ILC
RakhaInvasive lobular
carcinoma of the breast: response to hormonal therapy and outcomes		Eur J Cancer2008RetrospectiveClinicopathologicalAdjuvent Endocrine Therapy
RatzeLoss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancerOncogene2022Lab ResearchCancer BiologyE-Cadherin
RigginsERRγ
mediates Tamoxifen resistance in novel models of invasive lobular breast
cancer		Cancer Res2008Lab ResearchCancer biologyEndocrine Resistance
Reis-FilhoFGFR1
Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas		Clin Can Res2006RetrospectiveGenomicsFGFR1 mutation
RiedlingerTargetable
alterations in invasive pleomorphic lobular carcinoma of the breast		Breast Cancer Res2021RetrospectiveGenomicsPleomorphic ILC
RomanucciLobular Breast Cancer Conspicuity on Digital BreastTomosynthesis Compared to Synthesized 2D Mammography: A Multireader StudyJ Imaging2021RetrospectiveImagingImaging Modalities
Rosa-RosaHigh Frequency
of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with
Pleomorphic Features		Cancers2019RetrospectiveCancer biologyHer2(ERBB2) mutation in PLC
RossRelapsed
Classic E-Cadherin (CDH1)–Mutated Invasive Lobular Breast Cancer Shows
a High Frequency of HER2 (ERBB2) Gene Mutations		Clinical Cancer Research2013RetrospectiveGenomicsHER2(ERBB2) Mutation in iLC
RothschildObesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancerBreast Cancer Res Treat2021RetrospectiveRisk FactorsBMI
SahinInvasive Pleomorphic
Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients
with Breast Cancer		Am Surg2017RetrospectiveClinicopathologicalPleomorphic ILC
SawyerGenetic
Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast		PLOS2014RetrospectiveGenomicsGenetic Basis of ILC/LCIS
SchackmannCytosolic
p120-catenin regulates growth of metastatic lobular carcinoma through
Rock1-mediated anoikis resistance		J Clin Invest2011Lab ResearchCancer BiologyP120-Catenin
SchipperTruncated
ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via
Distinct Mechanisms		Cancer Res2020Lab ResearchCancer BiologyLab Models
SelinkoRole of sonography in
diagnosing and staging invasive lobular carcinoma		J Clin Ultrasound2004RetrospectiveImagingImaging Methods
SengerInvasive lobular
carcinoma of the male breast – a systematic review with an illustrative
case study		Breast Cancer2017Case ReportClinicopathologicalMale ILC
SestakPrognostic
Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative
Invasive Lobular Breast Cancer		Clin Cancer Res2020RetrospectivePrognosisPrognostic Biomarkers
SflomosAtlas of Lobular Breast Cancer Models: Challenges and Strategic DirectionsCancers2021ReviewCancer BiologyILC Models
SflomosIntraductal
xenografts show lobular carcinoma cells rely on their own extracellular
matrix and LOXL1		Embo Molecular Med2021Lab ResearchCancer biologyTumor microenvironment
ShacklefordEstrogen
Regulation of mTOR Signaling and Mitochondrial Function in Invasive Lobular
Carcinoma Cell Lines Requires WNT4		Cancers2020Lab ResearchCancer biologyEstrogen signaling
ShahPIK3CA mutations
are common in lobular carcinoma in situ, but are not a biomarker of
progression		Breast Cancer Res2017RetrospectiveGenomicsPIK3CA mutations in LCIS
ShamirGenetic analysis of
pleomorphic and florid lobular carcinoma in situ variants: frequent
ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma
in situ and invasivelobular carcinoma		Mod Pathol2020RetrospectiveGenomicsERBB2/3(Her2) mutation in
Pleomorphic and Florid LCIS/ILC
ShraderHereditary
diffuse gastric cancer: association with lobular breast cancer		Fam Cancer2008Case ReportClinicopathologicalHerditary CDH1 mutation
SikoraInvasive lobular
carcinoma of the breast: Patient response to systemic endocrine therapy and
hormone response in model systems		Steroids2012ReviewCancer biologyEndocrine Resistance
SikoraInvasive lobular
carcinoma cell lines are characterized by unique estrogen-mediated gene
expression patterns and altered tamoxifen response		Cancer Resarch2014Lab ResearchCancer biologyEndocrine response and resistance
SikoraWNT4 mediates
estrogen receptor signaling and endocrine resistance in invasive lobular
carcinoma cell lines		Breast Cancer Res2016Lab ResearchCancer biologyEndocrine response and resistance
SingletaryTreatment Trends
in Early-Stage Invasive Lobular Carcinoma		Ann Surgery2005RetrospectiveSurgerySurgical Methods
SledgeCollective
Wisdom: Lobular Carcinoma of the Breast		ASCO2016ReviewCancer biologyTherapy response and resistance
SokolLoss of function
of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular
breast cancer		Ann Oncol2018Lab ResearchGenomicsEndocrine Resistance
SonOncological
Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of
the Breast: A 20-Year Institutional Experience		Ann Surg Onc2020RetrospectiveSurgerySurgical Methods
SottnickMediator of DNA damage
checkpoint 1 (MDC1) is a novel estrogen receptor co-regulator in invasive
lobular carcinoma of the breast		Mol Cancer Res2021Lab ResearchCancer BiologyEstrogen Receptor
SreekumarDifferential
regulation and targeting of estrogen receptor α turnover in invasive
lobular breast carcinoma		Endocrinology2020Lab ResearchCancer BiologyEndocrine Response (SERDS)
StangeHigh-Resolution
Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and
16p with Histologic and Genetic Subgroups of IBC cell lines		Clinical Cancer Research2006RetrospectiveGenomicsGenomics of ILC
Strasser-WeipplOutcomes in women with
invasive ductal or invasive lobular early stage breast cancer treated with
anastrozole or exemestane		European Journal of Cancer2018RetrospectiveClinicopathologicalEndocrine Therapy
StiresIntegrated
Molecular Analysis of Tamoxifen-Resistant Invasive Lobular Breast Cancer
Cells Identifies MAPK and GRM/mGluR Signaling as Therapeutic Vulnerabilities		Mol Cell Endocrin2018Lab ResearchCell SignalingEndocrine Resistance
SumanAssociation of
variably methylated tumour DNA regions with overall survival for invasive
lobular breast cancer		Clin Epigenetics2021RetrospectiveGenomicsEpigenomics
SunDe novo metastatic lobular breast carcinoma: A population-based study from SEER databaseAsian J Surg2022RetrospectiveMetastasisPrognosis
SwitzerCase
series of 21 patients with extrahepatic metastatic lobular breast carcinoma
to the gastrointestinal tract		Cancer Treat Comm2015Case ReportMetastasisGI Metastasis
TalmanInvasive
lobular breast cancer. Prognostic significance of histological malignancy
grading		Acta Onc2006RetrospectiveClinicopathologicalPrognosis
TamarisaThe impact of
chemotherapy sequence on survival in node-positive invasive lobular carcinoma		J Surg Onco2019RetrospectiveClinicopathologicalChemotherapy
TasdemirComprehensive
phenotypic characterization of human invasive lobular carcinoma cell lines in
2D and 3D cultures		Cancer Resarch2018Lab ResearchCancer biologyLab models
Tenhagenp120-Catenin Is
Critical for the Development of Invasive Lobular Carcinoma in Mice		J Mamm Gland Biol Neo2016Lab ResearchCancer BiologyP120 Catenin
TeoE-cadherin loss
induces targetable autocrine activation of growth factor signalling in
lobular breast cancer		Scientific Reports2018Lab ResearchCancer biologyCell signaling
ThomasInvasive lobular breast
cancer: A review of pathogenesis, diagnosis, management, and future
directions of early stage disease		Semin Oncol2019ReviewClinicopathologicalNeoadjuvant Therapy
ThorntonNeoadjuvant Endocrine
Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular
Carcinoma		Ann Surg Oncol2019RetrospectiveClinicopathologicalNeoadjuvent Therapy Response
TilleTumor-infiltrating
lymphocytes are associated with poor prognosis in invasive lobular breast
carcinoma		Mod Pathol2020RetrospectiveCancer BiologyImmunology
TimbreSurvival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma. CancersCancers (Basel)2021RetrospectiveClinicopathologicalPrognosis
TrapaniBenefit
of Adjuvant Chemotherapy in Patients with Lobular Breast Cancer: a Systematic
Review of the Literature and Metanalysis		Cancer Treatment Review2021ReviewClinicopathologicalTherapy Response
TruinDifferences in
Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive
Lobular Versus Ductal Breast Cancer		Annals of Surgical Oncol2016RetrospectiveClinicopathologicalNeoadjuvent Chemotherapy
TsutsuiOrbital metastasis of invasive lobular carcinoma of the breastJ Surg Case Rep.2022Case StudyMetastasisOrbital Metastasis
UlanerProspective Clinical
Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant
Therapy in IDC and ILC		Journal of Nuclear Medicine2017ProspectiveImaging18 F-Fluciclovine PET/CT
UlanerHead-to-head evaluation of
18F-FES and 18F-FDG PET/CT in metastatic invasive lobular breast cancer		J Nu Med2020ReviewImagingFES PET/CT
Van BaelenCurrent and future diagnostic and treatment strategies for patients with invasive lobular breast cancerAnnals of Oncology2022ReviewClinicopathologicalTreatment Strategies
van de VenNuclear
p120-catenin regulates the anoikis resistance of mouse lobular breast cancer
cells through Kaiso-dependent Wnt11 expression		Dis Model Mech2015Lab ResearchCancer BiologyP120 Catenin
van de
Water		Influence
of semi-quantitative oestrogen receptor expression on adjuvant endocrine
therapy efficacy in ductal and lobular breast cancer		Eur J Cancer2012RetrospectiveClinicopathologicalAdjuvent Endocrine Therapy
van der
Post		Hereditary
diffuse gastric cancer: updated clinical guidelines with an emphasis on
germline CDH1 mutation carriers		J Med Genet2015ReviewRisk FactorsHereditary CDH1 Mutation
Van der
Veen		Extended
gene panel testing in lobular breast cancer		Familial Cancer2021RetrospectiveHereditary Breast CancerGermline (Herditary) Mutations
van MaarenTrends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysisThe Breast2021RetrospectiveIncidenceLCIS
VargasPleomorphic lobular
carcinoma of the breast: molecular pathology and clinical impact		Future Oncol2009ReviewGenomicsPleomorphic ILC
Venema18F-FES PET Has Added
Value in Staging and Therapy Decision Making in Patients With Disseminated
Lobular Breast Cancer.		Clin Nucl Med2017Laboratory ResearchImagingFES PET
VlugNuclear
localization of the transcriptional coactivator YAP is associated with
invasive lobular breast cancer		Cell Oncol2013Laboratory ResearchCancer BiologyCell Signaling
WalshBET Inhibition as a
Rational Therapeutic Strategy for Invasive Lobular Breast Cancer.		Clin Can Res2019Laboratory ResearchCancer BiologyNovel therapeutics
WangThe Distribution
and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen
Receptor-Positive Breast Cancer With Different Histologic Subtypes		Frontiers in Genetics2018RetrospectiveGenomicsPrognostic Biomarkers
WatanukiImpact of neoadjuvant and
adjuvant chemotherapy on invasive lobular carcinoma: A propensity
score-matched analysis of SEER data		Breast J2020RetrospectiveClinicopathologicalChemotherapy
WeiserAdjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysisCancer2022RetrospectiveClinicopathologicalAdjuvent Chemotherapy
WenLobular Cancer in SituSurg Pathol Clin2018RetrospectiveClinicopathologicalRisk Factors
WesthoffPrognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breastVirchous Archiv2020RetrospectiveClinicopathologicalTumor Microenvironment
WilliamsDifferences in
race, molecular and tumor characteristics among women diagnosed with invasive
ductal and lobular breast carcinomas		Cancer Causes2019RetrospectiveClinicopathologicalRacial Differences in ILC vs IDC
WilsonLobular Breast Cancer-A ReviewFrontiers in Oncology2021ReviewClinicopathologicalMolecular and Clinical features of ILC
WinstonMetastatic
Lobular Carcinoma of the Breast: Patterns of Spread in the Chest, Abdomen,
and Pelvis on CT		AJR2000RetrospectiveMetastasisMetastatic sites
WongInfiltrative pattern of metastatic invasive lobular breast carcinoma in the abdomen: a pictorial reviewInsights Imaging2021ReviewImagingAbdominal Metastasis
WongEvaluating the Impact of
Breast Density on Preoperative MRI in Invasive Lobular Carcinoma		J Am Coll Surg2018RetrospectiveImagingMRI
XiaoMixed invasive
ductal and lobular carcinoma has distinct clinical features and predicts
worse prognosis when stratified by estrogen receptor status		Scientific reports2017RetrospectiveClinicopathologicalMixed IDC/ILC
XicolaClinical features and
cancer risk in families with pathogenic CDH1 variants irrespective of
clinical criteria		J Med Genet2019RetrospectiveClinicopathologicalGenetic basis of ILC
XinA review of invasive lobular
carcinoma of the breast: Should it be treated like invasive ductal carcinoma?		Integr Cancer Sci Therapy2007ReviewClinicopathologicalPrognosis
YadavGermline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the BreastJ Clin onc2021RetrospectiveHereditary RiskGermline Mutations
YangComparison of
Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive
Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER
Database		Frontiers in Cancer2020RetrospectiveClinicopathologicalPrognosis
YasuiExpression of N-Terminal-Deficient E-Cadherin Protein in Invasive Lobular Carcinoma of the BreastAm J Surg pathol2021Lab ResearchTumor BiomarkersE-Cadherin
YuClassical-type
invasive lobular carcinoma with HER2 overexpression: clinical, histologic,
and hormone receptor characteristics		Am J Clinical Path2011Case ReportCancer biologyHER2 in ILC
ZhangBiomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosisBreast Cancer Res Treat2022RetrospectiveClinicopathologicalPleomorphic ILC

This document was last updated December 2023. 

For more information about lobular breast cancer or to make a gift visit lobularbreastcancer.org.

Stay Connected:

Facebook Linkedin Youtube Instagram
Subscribe
LBCA Logo White

Lobular Breast Cancer Alliance Inc. (LBCA) is a Delaware nonprofit corporation that is registered as a 501(c)(3) public charity. Tax ID Number: 86-2260246. Donations to LBCA are tax-deductible. to the fullest extent allowed by applicable law.

The LBCA Organization

DONATE
Find Support

info@lobularbreastcancer.org

© 2024 The Lobular Breast Cancer Alliance Inc. | Privacy Policy | Terms of Use | State Fundraising Notices

Site by SuzanneHarrisonWeb.com

Scroll to Top

Join Us

Subscribe for the Latest News & Updates​

  • This field is for validation purposes and should be left unchanged.